Error loading player: No playable sources found
244
Androgen Deficit in Younger and Aging Men: Diagnosis and Management
Date
October 13, 2013
Credits
1 CH | 1 Rx | 1 CME | Expired October 15, 2015
$20
Standard Price
This lecture will provide the advanced practice provider with an advanced level review of the pathophysiology of hypogonadism and evaluate current pharmacological treatments available in clinical practice.
Contact hours available until 10/11/2015.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.
Faculty, Planners, and Authors Conflict of Interest Disclosure:
Planning Commitee Disclosures:
Lee Ann Boyd, MSN, ARNO-C, CUNP / Presenter Bureau :Warner Chilcott
Leanne Schimke, MSN, CRNP-C CUNP/ Presenter :Amgen-Xgeva, Warner Chilott
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.
Objectives:
- Review normal androgenic function in adult and aging men.
- Discuss androgen deficiency in adult men.
- Define treatment options for managing androgen deficiency in adult populations including patients treated with androgen deprivation therapy for pros prostate cancer.
Speaker
Mikel Gray, PhD, FNP, PNP, CUNP, CCCN-AP, WOCNF, FAANP, FAAN
Professor and Nurse Practitioner, University of Virginia
Specialties
Related Products
Sex and Drugs
Information will be provided about some of the medications/drugs that impact sexual function and the most current pharmacological treatments for sexual dysfunction for the advanced practice provider…
Pelvic Muscle Rehabilitation: Nursing Guidelines for Practice
Clinical experts in the field of PMR will share their experience in treatment of men and women with PFD…
Castrate Resistant Prostate Cancer: The New Frontier in Treatment
In the last few years, advances in pharmacotherapy and immunotherapy have given new hope in castrate resistant prostate cancer with increases in overall survival up to 5.6 months. Advanced practice providers and nurses need to have an understanding of these treatments…
Painful Bladder Syndrome/Interstitial Cystitis
This lecture will provide advanced practice providers with the most current clinical information on managing painful bladder syndrome/interstitial cystitis. A review of current trends in pharmacological treatments will also be included…
